A diagnostic test being developed by a Kiwi researcher could help save the lives of pregnant women and their babies. Photo / 123RF
A diagnostic test being developed by a Kiwi researcher could help save the lives of pregnant women and their babies. Photo / 123RF
A new diagnostic test being developed by a Kiwi biochemist could help save the lives of pregnant women and their babies.
Pre-eclampsia is a life-threatening condition for both mother and child that occurs in around five per cent of pregnancies, and often requires early delivery of the baby.
Dr JenniferCrowther, a post-doctoral researcher at the University of Canterbury, said it remained one of the leading causes of maternal and foetal disease and death worldwide.
Being able to predict the risk for pre-eclamptic complications earlier could help doctors intervene with specialised care, close monitoring and targeted interventions.
A key indication of pre-eclampsia was higher levels of a specific protein in the mother's blood.
"While tests are available to assist in the diagnosis of established pre-eclampsia, these tests do not yet reliably predict the development of pre-eclampsia."
Dr Jennifer Crowther was also recently presented an Innovation Jumpstart award by Kiwinet chief executive James Hutchinson. Photo / Supplied
Current guidelines relied on the measurement of blood pressure and protein in the urine, however, these measurements had relatively low predictive accuracy.
"We need to increase the positive predictive power of tests for pre-eclampsia," she said.
This would allow those at risk to be closely monitored, while ruling out those who would not develop the condition.
"Risk factors for pre-eclampsia include obesity, existing hypertension and diabetes and given the increasing rates of obesity and high blood pressure nationally, this is a major health concern in New Zealand."
Crowther was recently awarded $100,000 from the Canterbury Medical Research Foundation to carry out her research.